We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,222

AOD-9604: patents, peptides, performance and.cellulite?
  • Phillips Ormonde Fitzpatrick
  • Australia
  • May 14 2013

Australia is no stranger to sporting scandals. Cricket's "John the bookmaker" affair, horse racing's "Fine Cotton" scandal and any number of player


Expect focus - volume III, Summer 2014
  • Carlton Fields
  • USA
  • September 16 2014

EXPECTFOCUS is a quarterly review of developments in the insurance and financial services industry, provided on a complimentary basis to clients and


Life Sciences Legal Trends in Canada
  • Borden Ladner Gervais LLP
  • Canada, European Union, United Kingdom, USA
  • June 6 2016

The doctrine of “sound prediction” was ushered into Canadian law as a means to protect useful inventions. A review of the case law, however, reveals


Supreme Court Corner - Q4 2016
  • DLA Piper LLP
  • USA
  • December 20 2016

The Digital Millennium Copyright Act (DMCA) protects web-based multimedia-sharing services, such as YouTube, from copyright infringement liability if


News and cases from China: August - September 2015
  • Rouse
  • China
  • October 29 2015

Recently, the National Copyright Administration issued Implementing Measures for the Copyright Administrative Penalties (Revision Draft for Comment


Noteworthy cases in the United States Supreme Court’s 2011 term
  • Larkin Hoffman
  • USA
  • September 21 2011

The first Monday in October represents the start of a new term for the United States Supreme Court


EMEA Healthcare Industry Group Newsletter - December 2015
  • Baker McKenzie
  • Belgium, European Union, Germany, Italy, Netherlands, Saudi Arabia, Spain, United Arab Emirates, United Kingdom
  • January 25 2016

The Eurasian Economic Union (EAEU) is introducing major new changes in the marketing of pharmaceuticals across its members - which include Russia


Amgen Inc. v. Apotex Inc
  • Winston & Strawn LLP
  • USA
  • August 29 2016

Amgen Inc. brought an action against Apotex Inc. under the Biologics Price Competition and Innovation Act (BPCIA) alleging that Apotex’s marketing of


China newsletter - summer 2013
  • Greenberg Traurig LLP
  • China, Macau
  • July 17 2013

For the purpose of fully implementing the spirit of the Eighteenth National Congress of the Communist Party of China and attracting more foreign


News Bytes
  • Shook Hardy & Bacon LLP
  • USA
  • February 27 2014

The U.S. Food and Drug Administration requests comments on the estimated time burdens of a proposed study that "will investigate the impact of